195 related articles for article (PubMed ID: 16375703)
1. Telomerase inhibition and cancer: might platinum based drugs have a future as anti-telomerase pharmacological approach?
Colangelo D; Osella D
Curr Med Chem; 2005; 12(26):3091-102. PubMed ID: 16375703
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
3. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
4. Telomerase inhibitors as anticancer therapy.
Akiyama M; Hideshima T; Munshi NC; Anderson KC
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724
[TBL] [Abstract][Full Text] [Related]
5. Telomerase inhibition as cancer therapy.
Saretzki G
Cancer Lett; 2003 May; 194(2):209-19. PubMed ID: 12757979
[TBL] [Abstract][Full Text] [Related]
6. Telomeres and telomerase: Pharmacological targets for new anticancer strategies?
Pendino F; Tarkanyi I; Dudognon C; Hillion J; Lanotte M; Aradi J; Ségal-Bendirdjian E
Curr Cancer Drug Targets; 2006 Mar; 6(2):147-80. PubMed ID: 16529544
[TBL] [Abstract][Full Text] [Related]
7. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
Rankin AM; Faller DV; Spanjaard RA
Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
[TBL] [Abstract][Full Text] [Related]
8. Recent patents on anti-telomerase cancer therapy.
Agrawal A; Dang S; Gabrani R
Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):102-17. PubMed ID: 21854360
[TBL] [Abstract][Full Text] [Related]
9. Anticancer therapy targeting telomeres and telomerase : current status.
Parkinson EK; Minty F
BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
[TBL] [Abstract][Full Text] [Related]
10. Telomerase inhibitors for the treatment of cancer: the current perspective.
Perry PJ; Arnold JR; Jenkins TC
Expert Opin Investig Drugs; 2001 Dec; 10(12):2141-56. PubMed ID: 11772310
[TBL] [Abstract][Full Text] [Related]
11. The significance of telomerase activation and cellular immortalization in human cancer.
Newbold RF
Mutagenesis; 2002 Nov; 17(6):539-50. PubMed ID: 12435851
[TBL] [Abstract][Full Text] [Related]
12. Might telomerase enzyme be a possible target for trans-Pt(II) complexes?
Colangelo D; Ghiglia A; Viano I; Mahboobi H; Ghezzi A; Cassino C; Osella D
J Inorg Biochem; 2004 Jan; 98(1):61-7. PubMed ID: 14659633
[TBL] [Abstract][Full Text] [Related]
13. Telomeres, telomerase and cancer: is the magic bullet real?
Sharma HW; Maltese JY; Zhu X; Kaiser HE; Narayanan R
Anticancer Res; 1996; 16(1):511-5. PubMed ID: 8615664
[TBL] [Abstract][Full Text] [Related]
14. The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review).
Engelhardt M; Martens UM
Oncol Rep; 1998; 5(5):1043-52. PubMed ID: 9683806
[TBL] [Abstract][Full Text] [Related]
15. Telomere length maintenance in aging and carcinogenesis.
Aragona M; Maisano R; Panetta S; Giudice A; Morelli M; La Torre I; La Torre F
Int J Oncol; 2000 Nov; 17(5):981-9. PubMed ID: 11029502
[TBL] [Abstract][Full Text] [Related]
16. Telomerase as a target for cancer therapy.
Parkinson KE
Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
[TBL] [Abstract][Full Text] [Related]
17. Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity.
Lee YH; Chen YY; Yeh YL; Wang YJ; Chen RJ
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159515
[No Abstract] [Full Text] [Related]
18. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
19. A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line.
Furuta M; Nozawa K; Takemura M; Izuta S; Murate T; Tsuchiya M; Yoshida K; Taka N; Nimura Y; Yoshida S
Int J Cancer; 2003 May; 104(6):709-15. PubMed ID: 12640677
[TBL] [Abstract][Full Text] [Related]
20. How to inhibit telomerase activity for cancer therapy.
Kyo S; Inoue M
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
